Skip to search formSkip to main contentSkip to account menu

panitumumab

Known as: panitumumab [Chemical/Ingredient], ABX-EGF, Clone E7.6.3, panitumumab antibody, human 
A human monoclonal antibody that is being used to treat colorectal cancer that has spread to other parts of the body. It is used in patients whose… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
*Department of Medical Microbiology, Immunology & Cell Biology, Simmons Cancer Institute, Southern Illinois University School of… 
2010
2010
3528^ Background: Pmab is a fully human antiepidermal growth factor receptor (EGFR) monoclonal antibody approved as monotherapy… 
2010
2010
3538 Background: Motesanib is an oral inhibitor of VEGF, PDFG, and Kit receptors. Pmab, a fully human monoclonal antibody against… 
2009
2009
Adenovirus early region 4 open reading frame 4 (E4orf4) protein is a novel cell death factor that selectively induces apoptosis… 
2005
2005
BACKGROUND The objective of this study was to investigate the comparative effects of heparin-binding epidermal growth factor-like… 
2002
2002
DANIEL J. TSCHUMPERLIN,1 JONATHAN D. SHIVELY,2 MELODY A. SWARTZ,2 ERIC S. SILVERMAN,2 KATHLEEN J. HALEY,2 GERHARD RAAB,3 AND… 
1986
1986
We have examined the effect of epidermal growth factor--urogastrone (EGF-URO) on the response of isolated canine helical… 
1981
1981
A radioreceptor assay for human epidermal growth factor-urogastrone (EGF-URO) employing mouse EGF-URO as tracer and calibration… 
1981
1981
The Rogers homeodynamic principles and holistic conceptual framework from which they are derived are useful for describing…